A comprehensive review on Brigatinib – A wonder drug for targeted cancer therapy in non-small cell lung cancer
This article is intended to provide readers with an overview of chemistry, pharmacokinetic, pharmacodynamic and safety profile of brigatinib, which addresses an unmet medical need.
Source: Saudi Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemistry | Genetics | Insulin | Lung Cancer | Lymphoma | Middle East Health | Non-Small Cell Lung Cancer | Saudi Arabia Health